FDA.reportPublic FDA data

pegzilarginase-nbln 2 MG per 0.4 ML Injection

RxCUI
2738664
RxNorm name
pegzilarginase-nbln 2 MG per 0.4 ML Injection
Display name
pegzilarginase-nbln 2 MG per 0.4 ML Injection
Full name
pegzilarginase-nbln 2 MG per 0.4 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761211Loargyspegzilarginase-nbln351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LoargysPEGZILARGINASE-NBLNImmedica Pharma US Inc.d5ceabf2-43a0-4746-9371-d98a39cf6cfc2026-02-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2738664

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d5ceabf2-43a0-4746-9371-d98a39cf6cfcpegzilarginase-nbln 2 MG per 0.4 ML InjectionSY1These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202620260223
d5ceabf2-43a0-4746-9371-d98a39cf6cfcpegzilarginase-nbln 5 MG/ML per 0.4 ML InjectionSY1These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202620260223
d5ceabf2-43a0-4746-9371-d98a39cf6cfc0.4 ML pegzilarginase-nbln 5 MG/ML InjectionSCD1These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202620260223
d5ceabf2-43a0-4746-9371-d98a39cf6cfcpegzilarginase-nbln 2 MG in 0.4 ML InjectionPSN1These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202620260223